Loading clinical trials...
Loading clinical trials...
The purpose of this trial is to investigate if maintenance DCVAC/OvCa after second-line chemotherapy of carboplatin/gemcitabine or carboplatin/paclitaxel improves efficacy outcomes in women with FIGO ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
SOTIO a.s.
NCT06888921 · Ovarian Cancer, Ovarian Cancer Recurrent
NCT06014528 · Ovarian Cancer Recurrent
NCT06660511 · Ovarian Cancer Recurrent
NCT03983226 · Ovarian Cancer Recurrent, Fallopian Tube Cancer, and more
NCT04175470 · Ovarian Cancer Recurrent
University Hospital Brno
Brno
Masaryk Memorial Cancer Institute
Brno
Hospital Novy Jicin
Nový Jičín
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions